中商官网
研究报告
蔚蓝生物（603739）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2014 | 728000000.0000 | 46596600.0000 | 79390600.0000 | 59650700.0000 | 795000000.0000 | 329000000.0000 | 466000000.0000 |
| 2015 | 752000000.0000 | 68438000.0000 | 97881500.0000 | 77673900.0000 | 822000000.0000 | 302000000.0000 | 519000000.0000 |
| 2016 | 781000000.0000 | 94680600.0000 | 114000000.0000 | 89490000.0000 | 828000000.0000 | 270000000.0000 | 558000000.0000 |
| 2017 | 799000000.0000 | 115000000.0000 | 117000000.0000 | 92530100.0000 | 884000000.0000 | 291000000.0000 | 593000000.0000 |
| 2018 | 814000000.0000 | 109000000.0000 | 112000000.0000 | 92939100.0000 | 945000000.0000 | 314000000.0000 | 631000000.0000 |
| 2019 | 847000000.0000 | 97790300.0000 | 97606500.0000 | 89391400.0000 | 1281000000.0000 | 249000000.0000 | 1032000000.0000 |
| 2020 | 960000000.0000 | 142000000.0000 | 140000000.0000 | 122000000.0000 | 1451000000.0000 | 336000000.0000 | 1115000000.0000 |
| 2021 | 1151000000.0000 | 171000000.0000 | 171000000.0000 | 150000000.0000 | 2222000000.0000 | 536000000.0000 | 1686000000.0000 |
| 2022 | 1163000000.0000 | 103000000.0000 | 102000000.0000 | 85411300.0000 | 2579000000.0000 | 845000000.0000 | 1734000000.0000 |
| 2023 | 1199000000.0000 | 123000000.0000 | 122000000.0000 | 103000000.0000 | 3034000000.0000 | 1209000000.0000 | 1825000000.0000 |
| 2024 | 1321000000.0000 | 124000000.0000 | 123000000.0000 | 92172300.0000 | 2981000000.0000 | 1111000000.0000 | 1870000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2014 | 5.36 | 10.91 | 9.99 | 12.8200 | 3.9400 | 5.86 | 0.92 |
| 2015 | 8.64 | 13.02 | 11.91 | 15.7400 | 4.6700 | 5.25 | 0.91 |
| 2016 | 12.04 | 14.60 | 13.77 | 16.7200 | 4.7600 | 4.93 | 0.94 |
| 2017 | 12.27 | 14.64 | 13.24 | 16.4100 | 4.6600 | 5.54 | 0.90 |
| 2018 | 11.55 | 13.76 | 11.85 | 15.5500 | 4.4100 | 5.79 | 0.86 |
| 2019 | 7.08 | 11.52 | 7.62 | 8.5500 | 4.2700 | 5.40 | 0.66 |
| 2020 | 11.15 | 14.58 | 9.65 | 10.9200 | 4.2600 | 5.41 | 0.66 |
| 2021 | 10.86 | 14.86 | 7.70 | 9.4200 | 4.3900 | 5.28 | 0.52 |
| 2022 | 5.76 | 8.77 | 3.96 | 4.3000 | 3.9900 | 4.25 | 0.45 |
| 2023 | 7.09 | 10.18 | 4.02 | 4.8200 | 3.4000 | 3.86 | 0.40 |
| 2024 | 6.81 | 9.31 | 4.13 | 3.6400 | 3.6800 | 3.92 | 0.44 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2014 | 41.38 | 58.62 | 1.7300 | 1.1800 |
| 2015 | 36.74 | 63.14 | 1.7600 | 1.3300 |
| 2016 | 32.61 | 67.39 | 2.0200 | 1.5400 |
| 2017 | 32.92 | 67.08 | 1.9400 | 1.4700 |
| 2018 | 33.23 | 66.77 | 1.8200 | 1.3400 |
| 2019 | 19.44 | 80.56 | 3.8400 | 3.0100 |
| 2020 | 23.16 | 76.84 | 2.7200 | 2.0600 |
| 2021 | 24.12 | 75.88 | 2.6100 | 2.0800 |
| 2022 | 32.76 | 67.24 | 1.5000 | 1.1900 |
| 2023 | 39.85 | 60.15 | 1.0300 | 0.8200 |
| 2024 | 37.27 | 62.73 | 1.0400 | 0.8300 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2014 | 689000000.0000 | 142000000.0000 | 187000000.0000 | 6767700.0000 |
| 2015 | 687000000.0000 | 142000000.0000 | 84858000.0000 | 6265500.0000 |
| 2016 | 687000000.0000 | 149000000.0000 | 84645500.0000 | 4337300.0000 |
| 2017 | 701000000.0000 | 148000000.0000 | 83010200.0000 | 4319800.0000 |
| 2018 | 720000000.0000 | 142000000.0000 | 80764900.0000 | 4355400.0000 |
| 2019 | 787000000.0000 | 173000000.0000 | 91082100.0000 | 1881100.0000 |
| 2020 | 853000000.0000 | 163000000.0000 | 94646000.0000 | 4541300.0000 |
| 2021 | 1026000000.0000 | 180000000.0000 | 105000000.0000 | 3140600.0000 |
| 2022 | 1096000000.0000 | 177000000.0000 | 121000000.0000 | 5276000.0000 |
| 2023 | 1114000000.0000 | 190000000.0000 | 125000000.0000 | 15218200.0000 |
| 2024 | 1231000000.0000 | 197000000.0000 | 147000000.0000 | 21878800.0000 |